These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 506277)

  • 1. [Value of verapamil in long-term treatment of coronary disease, hypertension and functional disorders of the cardiovascular system].
    Tkaczewski W; Goch JH
    Wiad Lek; 1979 Oct; 32(19):1359-62. PubMed ID: 506277
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term administration of verapamil in coronary disease].
    Tkaczewski W; Goch JH; Bala T; Kuklewicz C
    Pol Tyg Lek; 1977 Oct; 32(44):1719-21. PubMed ID: 917918
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium channel blockers. New treatment for cardiovascular disease.
    Rossi LP; Antman EM
    Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nifedipine and verapamil in the treatment of ischemic heart disease and hypertension].
    Metelitsa VI; Slastnikova ID; Matsevich SIu; Kokurina EV; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):113-8. PubMed ID: 2604882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta blockaders and the cardiovascular system].
    Romeo F
    G Clin Med; 1979 May; 60(5):319-34. PubMed ID: 39859
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
    Candau LA; Padilha JC; Tasca R; de Patta M; Weiskopf JS; Scherr C
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():51-62. PubMed ID: 678165
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of arterial hypertension with verapamil.
    Wigler I; Peer G; Soferman G; Blum M; Aviram A
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):162-6. PubMed ID: 6715085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil in hypertension--a long term study.
    Zawar PB; Chawhan RN; Gosavi SV; Gokhale PD; Jadhav AB
    Indian Heart J; 1982; 34(1):38-41. PubMed ID: 7084985
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous verapamil in the treatment of acute coronary insufficiency].
    Albuquerque DC; da Rocha PJ; Albanesi Filho FM; Benchimol CB; Albuquerque EN; Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1979 Apr; 32(4):269-72. PubMed ID: 508109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Verapamil for regulation of cardiac rhythm disorders. Experience with our own patients].
    Arsov D; Serafimova E
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1290+. PubMed ID: 4098330
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of isoptin on hemodynamics in patients with hypertension and ischemic heart disease].
    Zaslavskaia RM; Budenova LA; Vilkovyskiĭ FA; Malkin LM; Olevskiĭ IKh
    Klin Med (Mosk); 1985 Aug; 63(8):33-6. PubMed ID: 3908807
    [No Abstract]   [Full Text] [Related]  

  • 16. A symposium: Cardiovascular therapy--the next step. Southampton, Bermuda. Proceedings.
    Am J Cardiol; 1989 Sep; 64(11):1F-69F. PubMed ID: 2782267
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term use of heparin in cardiovascular diseases. Proposal for a new administration method: aerosols].
    Molino N; Belluardo C
    Minerva Cardioangiol; 1973; 21(7):553-7. PubMed ID: 4756349
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil in cardiology.
    Krikler D
    Eur J Cardiol; 1974 Aug; 2(1):3-10. PubMed ID: 4153535
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of verapamil on reinfarction and cardiovascular events in patients with arterial hypertension included in the Danish Verapamil Infarction Trial II. The Danish Study Group on Verapamil in Myocardial Infarction.
    Jespersen CM; Hansen JF
    J Hum Hypertens; 1994 Feb; 8(2):85-8. PubMed ID: 8207744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.